Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Molecular Diagnostics Receives CLIA Certification

NEW YORK, March 31 (GenomeWeb News) - CombiMatrix Molecular Diagnostics has received CLIA certification to operate as a clinical laboratory, the company announced today.

 

Matt Watson, CEO of CMDX, said his company had been working to establish processes and procedures that would meet CLIA's quality control and quality assurance standards since it opened in May 2005.

 

CMDX is a wholly owned subsidiary of CombiMatrix, which is a unit of Acacia Research.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.